Barinthus Biotherapeutics
BRNS----
Forecast & Rating3 analysts currently cover Barinthus Biotherapeutics, of which 2 give a positive rating. The average price target is $5.50, about 813.6% upside from the current price of $0.60. Coverage is limited, so the data is for reference only. Data as of Mar 15, 2026; this does not constitute investment advice.
Mar 13, 2026Price forecast
$5.50813.62%
Forecast & RatingStrong buy
2analysts
- Strong buy100.00%
- Buy0.00%
- Hold0.00%
- Sell0.00%
- Strong sell0.00%
Target price forecast
Forecast baselineJul 19, 2026
Forecast met0.0%
Stock price$0.60
Average forecast price$5.5
Highest forecast price$7
Lowest forecast price$4
Analyst ratings
Strong buy
Buy
Hold
Sell
Strong sell
Source: S&P Global
This information is for reference only and is not investment advice.